private:xagenic
|
1989893
|
Oct 26th, 2020 12:00AM
|
Xagenic Inc.
|
2.5K
|
6.00
|
Open
|
Medical Device
|
Oct 26th, 2020 03:51PM
|
Oct 26th, 2020 03:51PM
|
Xagenic is a molecular diagnostics company developing a true point- of-care platform. Our aim is to enable on-demand, near patient molecular testing, empowering clinicians in making treatment decisions for their patients at the time of first consultation. This will dramatically improve patient care and reduce health care costs.
We are commercializing a simple and fully automated technology platform that will enable widespread decentralized diagnostic testing to be performed outside of clinical laboratories. Our team is developing infectious disease tests that will allow the detection of a variety of analytes in situations where rapid test turnaround will provide clinically actionable results.
|
Open
|
|
Open
|
|
|
|
|
|
|
Xagenic
|
|
Pharmaceuticals & Biotechnology
|
private:xagenic
|
1989893
|
Oct 25th, 2020 12:00AM
|
Xagenic Inc.
|
2.5K
|
6.00
|
Open
|
Medical Device
|
Oct 24th, 2020 09:44PM
|
Oct 25th, 2020 07:49PM
|
Xagenic is a molecular diagnostics company developing a true point- of-care platform. Our aim is to enable on-demand, near patient molecular testing, empowering clinicians in making treatment decisions for their patients at the time of first consultation. This will dramatically improve patient care and reduce health care costs.
We are commercializing a simple and fully automated technology platform that will enable widespread decentralized diagnostic testing to be performed outside of clinical laboratories. Our team is developing infectious disease tests that will allow the detection of a variety of analytes in situations where rapid test turnaround will provide clinically actionable results.
|
Open
|
|
Open
|
|
|
|
|
|
|
Xagenic
|
|
Pharmaceuticals & Biotechnology
|
private:xagenic
|
1989893
|
Oct 23rd, 2020 12:00AM
|
Xagenic Inc.
|
2.5K
|
6.00
|
Open
|
Medical Device
|
Oct 23rd, 2020 07:34PM
|
Oct 23rd, 2020 07:34PM
|
Xagenic is a molecular diagnostics company developing a true point- of-care platform. Our aim is to enable on-demand, near patient molecular testing, empowering clinicians in making treatment decisions for their patients at the time of first consultation. This will dramatically improve patient care and reduce health care costs.
We are commercializing a simple and fully automated technology platform that will enable widespread decentralized diagnostic testing to be performed outside of clinical laboratories. Our team is developing infectious disease tests that will allow the detection of a variety of analytes in situations where rapid test turnaround will provide clinically actionable results.
|
Open
|
|
Open
|
|
|
|
|
|
|
Xagenic
|
|
Pharmaceuticals & Biotechnology
|
private:xagenic
|
1989893
|
Oct 22nd, 2020 12:00AM
|
Xagenic Inc.
|
2.5K
|
6.00
|
Open
|
Medical Device
|
Oct 22nd, 2020 04:09PM
|
Oct 22nd, 2020 04:09PM
|
Xagenic is a molecular diagnostics company developing a true point- of-care platform. Our aim is to enable on-demand, near patient molecular testing, empowering clinicians in making treatment decisions for their patients at the time of first consultation. This will dramatically improve patient care and reduce health care costs.
We are commercializing a simple and fully automated technology platform that will enable widespread decentralized diagnostic testing to be performed outside of clinical laboratories. Our team is developing infectious disease tests that will allow the detection of a variety of analytes in situations where rapid test turnaround will provide clinically actionable results.
|
Open
|
|
Open
|
|
|
|
|
|
|
Xagenic
|
|
Pharmaceuticals & Biotechnology
|
private:xagenic
|
1989893
|
Oct 21st, 2020 12:00AM
|
Xagenic Inc.
|
2.5K
|
6.00
|
Open
|
Medical Device
|
Oct 21st, 2020 03:53PM
|
Oct 21st, 2020 03:53PM
|
Xagenic is a molecular diagnostics company developing a true point- of-care platform. Our aim is to enable on-demand, near patient molecular testing, empowering clinicians in making treatment decisions for their patients at the time of first consultation. This will dramatically improve patient care and reduce health care costs.
We are commercializing a simple and fully automated technology platform that will enable widespread decentralized diagnostic testing to be performed outside of clinical laboratories. Our team is developing infectious disease tests that will allow the detection of a variety of analytes in situations where rapid test turnaround will provide clinically actionable results.
|
Open
|
|
Open
|
|
|
|
|
|
|
Xagenic
|
|
Pharmaceuticals & Biotechnology
|
private:xagenic
|
1989893
|
Oct 20th, 2020 12:00AM
|
Xagenic Inc.
|
2.5K
|
6.00
|
Open
|
Medical Device
|
Oct 20th, 2020 05:04PM
|
Oct 20th, 2020 05:04PM
|
Xagenic is a molecular diagnostics company developing a true point- of-care platform. Our aim is to enable on-demand, near patient molecular testing, empowering clinicians in making treatment decisions for their patients at the time of first consultation. This will dramatically improve patient care and reduce health care costs.
We are commercializing a simple and fully automated technology platform that will enable widespread decentralized diagnostic testing to be performed outside of clinical laboratories. Our team is developing infectious disease tests that will allow the detection of a variety of analytes in situations where rapid test turnaround will provide clinically actionable results.
|
Open
|
|
Open
|
|
|
|
|
|
|
Xagenic
|
|
Pharmaceuticals & Biotechnology
|
private:xagenic
|
1989893
|
Oct 19th, 2020 12:00AM
|
Xagenic Inc.
|
2.5K
|
6.00
|
Open
|
Medical Device
|
Oct 19th, 2020 05:19PM
|
Oct 19th, 2020 05:19PM
|
Xagenic is a molecular diagnostics company developing a true point- of-care platform. Our aim is to enable on-demand, near patient molecular testing, empowering clinicians in making treatment decisions for their patients at the time of first consultation. This will dramatically improve patient care and reduce health care costs.
We are commercializing a simple and fully automated technology platform that will enable widespread decentralized diagnostic testing to be performed outside of clinical laboratories. Our team is developing infectious disease tests that will allow the detection of a variety of analytes in situations where rapid test turnaround will provide clinically actionable results.
|
Open
|
|
Open
|
|
|
|
|
|
|
Xagenic
|
|
Pharmaceuticals & Biotechnology
|
private:xagenic
|
1989893
|
Oct 18th, 2020 12:00AM
|
Xagenic Inc.
|
2.5K
|
6.00
|
Open
|
Medical Device
|
Oct 17th, 2020 09:35PM
|
Oct 17th, 2020 09:35PM
|
Xagenic is a molecular diagnostics company developing a true point- of-care platform. Our aim is to enable on-demand, near patient molecular testing, empowering clinicians in making treatment decisions for their patients at the time of first consultation. This will dramatically improve patient care and reduce health care costs.
We are commercializing a simple and fully automated technology platform that will enable widespread decentralized diagnostic testing to be performed outside of clinical laboratories. Our team is developing infectious disease tests that will allow the detection of a variety of analytes in situations where rapid test turnaround will provide clinically actionable results.
|
Open
|
|
Open
|
|
|
|
|
|
|
Xagenic
|
|
Pharmaceuticals & Biotechnology
|
private:xagenic
|
1989893
|
Oct 17th, 2020 12:00AM
|
Xagenic Inc.
|
2.5K
|
6.00
|
Open
|
Medical Device
|
Oct 16th, 2020 09:22PM
|
Oct 16th, 2020 09:22PM
|
Xagenic is a molecular diagnostics company developing a true point- of-care platform. Our aim is to enable on-demand, near patient molecular testing, empowering clinicians in making treatment decisions for their patients at the time of first consultation. This will dramatically improve patient care and reduce health care costs.
We are commercializing a simple and fully automated technology platform that will enable widespread decentralized diagnostic testing to be performed outside of clinical laboratories. Our team is developing infectious disease tests that will allow the detection of a variety of analytes in situations where rapid test turnaround will provide clinically actionable results.
|
Open
|
|
Open
|
|
|
|
|
|
|
Xagenic
|
|
Pharmaceuticals & Biotechnology
|
private:xagenic
|
1989893
|
Oct 15th, 2020 12:00AM
|
Xagenic Inc.
|
2.5K
|
6.00
|
Open
|
Medical Device
|
Oct 15th, 2020 02:48PM
|
Oct 15th, 2020 02:48PM
|
Xagenic is a molecular diagnostics company developing a true point- of-care platform. Our aim is to enable on-demand, near patient molecular testing, empowering clinicians in making treatment decisions for their patients at the time of first consultation. This will dramatically improve patient care and reduce health care costs.
We are commercializing a simple and fully automated technology platform that will enable widespread decentralized diagnostic testing to be performed outside of clinical laboratories. Our team is developing infectious disease tests that will allow the detection of a variety of analytes in situations where rapid test turnaround will provide clinically actionable results.
|
Open
|
|
Open
|
|
|
|
|
|
|
Xagenic
|
|
Pharmaceuticals & Biotechnology
|